Physician profile
Frank Armocida
NPI 1720176126
$22,715.40
in general payments reported to CMS, 2019-2025
31 companies · $822 in 2025
The $822 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $625 · 2021: $391 · 2022: $240 · 2023: $3,287 · 2024: $17K · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $3,555 · Food and Beverage: $2,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,400.00 |
| Travel and Lodging | $3,555.39 |
| Food and Beverage | $2,795.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $19,482.71 | 2019-2025 | Ezout, Surg - Interpulse, Orthomap |
| Pacira Therapeutics, INC. | $1,135.71 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $324.16 | 2020-2025 | Euflexxa |
| Anika Therapeutics, INC. | $311.09 | 2022-2024 | Integrity |
| Smith+Nephew, INC. | $206.46 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Na, Pico |
| Microport Orthopedics INC | $186.52 | 2023 | Mpo Medial Pivot Knee |
| Bioventus LLC | $135.41 | 2019-2023 | Exogen Ultrasound Bone Healing System, Durolane |
| Depuy Synthes Sales INC. | $95.87 | 2023-2025 | Monovisc, Orthovisc |
| Medtronic, INC. | $88.99 | 2024-2025 | Aquamantys(Tm), Inceptiv |
| Peerless Surgical INC. | $76.38 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $60.31 | 2023-2025 | Zilretta, Iovera, Exparel |
| Aesculap, INC. | $56.04 | 2023 | Elan 4 |
| Horizon Therapeutics Plc | $50.19 | 2019-2022 | |
| Pfizer INC. | $49.50 | 2020-2021 | |
| Inari Medical, INC. | $48.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $43.87 | 2023 | Xvision |
| Vertex Pharmaceuticals Incorporated | $41.88 | 2025 | |
| Treace Medical Concepts, INC. | $41.00 | 2025 | |
| Medtronic USA, INC. | $40.83 | 2019 | |
| Cerapedics INC. | $31.11 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Acera Surgical, INC. | $26.05 | 2025 | Restrata Wound Matrix |
| Si-Bone, INC. | $23.51 | 2024 | |
| Davol INC. | $23.23 | 2022 | |
| Heron Therapeutics, INC. | $22.83 | 2024 | Zynrelef |
| Boston Scientific Corporation | $22.22 | 2024 | |
| Sanara Medtech INC. | $18.86 | 2022 | |
| Solventum Corporation | $16.38 | 2025 | Prevena |
| Curonix LLC | $15.48 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ermi LLC | $14.97 | 2019 | |
| Innovation Technologies INC | $13.80 | 2025 | Irrisept |
| Avanos Medical | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Armocida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.